Immunocore Holdings Plc ADR (IMCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 40,179 | 30,156 | 8,881 | 8,169 | 8,014 |
| Cost of Goods | 43 | 333 | N/A | N/A | N/A |
| Gross Profit | 40,136 | 29,823 | 8,881 | 8,169 | 8,014 |
| Operating Expenses | 48,958 | 52,242 | 59,879 | 50,846 | 56,236 |
| Operating Income | -8,780 | -22,086 | -50,998 | -42,677 | -48,223 |
| Interest Expense | 1,754 | 1,789 | 1,812 | 1,816 | 1,800 |
| Other Income | 148 | 13 | 6 | 11 | 17 |
| Pre-tax Income | -10,386 | -23,861 | -52,803 | -44,482 | -50,006 |
| Income Tax | -2,701 | -2,221 | 385 | -2,930 | -3,932 |
| Net Income Continuous | -7,685 | -21,641 | -53,188 | -41,552 | -46,074 |
| Net Income | $-7,685 | $-21,641 | $-53,188 | $-41,552 | $-46,074 |
| EPS Basic Total Ops | -0.18 | -0.50 | -1.21 | -0.95 | -1.05 |
| EPS Basic Continuous Ops | -0.17 | -0.49 | -1.21 | -0.95 | -1.05 |
| EPS Diluted Total Ops | -0.18 | -0.50 | -1.21 | -0.95 | -1.05 |
| EPS Diluted Continuous Ops | -0.17 | -0.49 | -1.21 | -0.95 | -1.05 |
| EBITDA(a) | $-6,868 | $-19,833 | $-48,655 | $-40,383 | $-45,709 |